Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve

Rashmi Kumari1, Martin R Silic1, Yava L Jones-Hall1,2

  • 1Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana 47907, USA.

Oncotarget
|May 29, 2018
PubMed

Insights

The RECK gene acts as a tumor suppressor, inhibiting the growth of malignant peripheral nerve sheath tumors (MPNSTs). Restoring RECK in human MPNST cells offers a potential new therapeutic strategy for this aggressive cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with poor prognoses.
  • Chromosome 9p deletions are common in MPNSTs, but key cancer driver genes remain largely unidentified.
  • RECK was previously proposed as a tumor suppressor candidate on chromosome 9p.

Purpose of the Study:

  • To investigate the role of the RECK gene in MPNST tumorigenesis using zebrafish models.
  • To examine the therapeutic potential of RECK gene restoration in human MPNST cell lines.

Main Methods:

  • Utilized zebrafish genetic models with tp53 and ribosomal protein gene mutations.
  • Assessed the impact of RECK gene restoration on human MPNST cell line growth.

Main Results:

  • Provided the first genetic evidence that RECK functions as a bona fide tumor suppressor gene in MPNSTs within zebrafish.
  • Demonstrated that RECK gene restoration inhibits growth in human MPNST cells.

Conclusions:

  • RECK is a critical tumor suppressor gene for MPNST development.
  • Reactivating RECK presents a promising therapeutic avenue for MPNST treatment.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K